<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="en">Medical Herald of the South of Russia</journal-title><trans-title-group xml:lang="ru"><trans-title>Медицинский вестник Юга России</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2021-12-4-12-19</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-1441</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OBSTETRICS AND GYNECOLOGY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АКУШЕРСТВО И ГИНЕКОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>Preterm and term rupture of the amniotic sac in the third trimester: outcomes for mother and child</article-title><trans-title-group xml:lang="ru"><trans-title>Преждевременный и своевременный разрыв околоплодного пузыря в третьем триместре: исходы для матери и ребенка</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8885-1587</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Енькова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Enkova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Владимировна Енькова, доктор медицинских наук, заведующая кафедрой акушерства и гинекологии №2</p><p>Воронеж</p></bio><bio xml:lang="en"><p>Elena V. Enkova, Dr. Sci. (Med.), Professor at the Department of Obstetrics and Gynecology №2</p><p>Voronezh</p></bio><email xlink:type="simple">enkova@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2617-7723</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фомина</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Fomina</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анна Сергеевна Фомина, аспирант по научной специальности 14.01.01 — Акушерство и гинекология</p><p>Воронеж</p></bio><bio xml:lang="en"><p>Anna S. Fomina, Post-graduate Student in Scientific Specialty 14.01.01 — Obstetrics and Gynecology</p><p>Voronezh</p></bio><email xlink:type="simple">asfomina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3383-5755</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Енькова</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Enkova</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Валерия Вадимовна Енькова, кандидат медицинских наук, ассистент кафедры акушерства и гинекологии №2</p><p>Воронеж</p></bio><bio xml:lang="en"><p>Valeria V. Enkova, Cand. Sci. (Med.), Assistance Lecturer of the Department of Obstetrics and Gynecology № 2</p><p>Voronezh</p></bio><email xlink:type="simple">enkova_lera@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4199-8156</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хоперская</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Khoperskaya</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Викторовна Хоперская, кандидат медицинских наук, ассистент кафедры акушерства и гинекологии №2</p><p>Воронеж</p><p> </p></bio><bio xml:lang="en"><p>Olga V. Khoperskaya, Cand. Sci. (Med.), Assistance Lecturer of the Department of Obstetrics and Gynecology № 2</p><p>Voronezh</p></bio><email xlink:type="simple">smv250587@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Воронежский государственный медицинский университет им. Н.Н. Бурденко</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Burdenko Voronezh State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>25</day><month>12</month><year>2021</year></pub-date><volume>12</volume><issue>4</issue><fpage>12</fpage><lpage>19</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Enkova E.V., Fomina A.S., Enkova V.V., Khoperskaya O.V., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Енькова Е.В., Фомина А.С., Енькова В.В., Хоперская О.В.</copyright-holder><copyright-holder xml:lang="en">Enkova E.V., Fomina A.S., Enkova V.V., Khoperskaya O.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1441">https://www.medicalherald.ru/jour/article/view/1441</self-uri><abstract><sec><title>Objective</title><p>Objective: To evaluate the characteristics of women in labor and pregnancy outcomes at different gestational periods with preterm prelabor rupture of membranes (PPROM) and preterm rupture of membranes (PROM) in the third trimester of pregnancy.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods: The study included pregnant women in the third trimester, at the gestation period of 28-41.6 weeks of pregnancy, divided into groups of PROM and PPROM: 173 (80.8%) and 41 (19.2%) pregnant women, respectively.</p></sec><sec><title>Results</title><p>Results: It was found that PPROM is associated with a significantly lower gestational age, higher levels of C-reactive protein, and higher body temperature upon admission to the maternity hospital (P &lt;0.05). Breech presentation and history of cesarean section were significantly associated with PPROM (P &lt; 0.05), rather than PROM. The PPROM group had a significantly longer latency period compared to the PROM group, in which the latency period increased with a lower gestational age (28–31.6 weeks). A significantly higher rate of admission to the neonatal intensive care unit (NICU) was observed in the PPROM group compared to the PROM group. Also, at the gestational age of 28-31.6 weeks, a significantly higher rate of admission to the NICU was revealed compared to the gestational age of 32-36. 6 weeks (P &lt; 0.05).</p></sec><sec><title>Conclusions</title><p>Conclusions: The purpose of this retrospective study was to evaluate the characteristics of women in labor and pregnancy outcomes at different gestational periods with PPROM and PROM in the third trimester of pregnancy.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Цель</title><p>Цель: оценка характеристик рожениц и исходов беременности на различном гестационном сроке у пациентов с преждевременным дородовым разрывом плодных оболочек (ПДРПО) и преждевременным разрывом плодных оболочек (ПРПО) в третьем триместре беременности.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы: в исследование были включены беременные в третьем триместре, в сроке гестации 28–41,6 недель беременности, разделённые на группы ПРПО и ПДРПО: 173 (80,8%) беременные с ПРПО и 41 (19,2%) беременная с ПДРПО.</p></sec><sec><title>Результаты</title><p>Результаты: ПДРПО связан со значительно более низким гестационным возрастом, у пациентов этой группы выявлен более высокий уровень С-реактивного белка и температуры тела при поступлении в родильный дом (p&lt;0,05). Тазовое предлежание и предыдущее кесарево сечение в анамнезе были связаны с возникновением ПДРПО в сравнении с группой ПРПО (p&lt;0,05). В группе ПДРПО отмечен значительно более длительный безводный период в сравнении с группой ПРПО, в которой безводный период увеличивался с меньшим гестационным возрастом (28–31,6 недель). Значительно более высокий уровень поступления в отделение интенсивной терапии новорождённых (ОРИТ) отмечался в группе ПДРПО в сравнении с группой ПРПО, а также при гестационном возрасте 28–31,6 недель был выявлен более значительный показатель поступления в ОРИТ в сравнении с гестационным возрастом 32–36,6 недель (p&lt;0,05).</p></sec><sec><title>Выводы</title><p>Выводы: на основе выявленных данных дополнены рекомендации к диагностике преждевременных родов и ПДРПО.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>преждевременные и срочные роды</kwd><kwd>преждевременный разрыв плодных оболочек</kwd><kwd>безводный период</kwd><kwd>факторы риска</kwd></kwd-group><kwd-group xml:lang="en"><kwd>preterm and urgent childbirth</kwd><kwd>preterm rupture of membranes</kwd><kwd>latency period</kwd><kwd>risk factors</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>The problem of preterm rupture of membranes (PROM) still does not lose its relevance in modern obstetrics. Despite the amount of accumulated knowledge about the causes of PROM, the question of the etiology and risk groups of this pregnancy complication remains open to date. Preterm rupture of membranes (PROM) is a spontaneous rupture of the fetal bladder before the start of regular contractions. Childbirth complicated by premature discharge of amniotic fluid during full-term pregnancy, according to various data, ranges from 8.2% to 19.6%, with premature birth (up to 37 weeks of gestation) – from 5 to 35%, without a tendency to decrease. It should also be noted that PROM tends to re-develop in subsequent births with a frequency of up to 20-32% [<xref ref-type="bibr" rid="cit1">1</xref>][<xref ref-type="bibr" rid="cit2">2</xref>].</p><p>In most cases, PROM occurs on the eve of childbirth, however, when the rupture of membranes occurs before the 37th week of pregnancy, it is called preterm prelabor rupture of membranes (PPROM). PPROM is one of the clinical forms of preterm labor, which occurs in ~ 3% of pregnancies, leading to one-third of preterm labor. It remains the main cause of premature birth, neonatal mortality and morbidity [<xref ref-type="bibr" rid="cit3">3</xref>]. Premature birth can be subdivided according to gestational age: about 5% of premature births occur at less than 28 weeks (very early premature birth), ~ 15% – at 28-34 weeks (early premature birth), ~ 20% – at 34-36.6 weeks (premature birth).</p><p>Factors associated with PPROM include lower socio-economic status, previous preterm labor, previous PROM, sexually transmitted diseases, vaginal bleeding, connective tissue disorders, smoking, and uterine overgrowth. However, there are cases when the causes of PROM are unclear. The clinical significance and treatment of PPROM are still controversial. Despite the fact that PROM is associated with a lower rate of complications, PROM can lead to significant neonatal and maternal morbidity [<xref ref-type="bibr" rid="cit4">4</xref>][<xref ref-type="bibr" rid="cit5">5</xref>].</p></sec><sec><title>Methods and materials</title><p>The first general blood test (GBT) and the level of C-reactive protein (CRP) were recorded when pregnant women were admitted to the maternity hospital. The diagnosis of PROM and PPROM was based on anamnesis, objective examination and laboratory studies of pregnant women. Gestational age was determined from the date of the last menstruation or ultrasound in the period up to 12 weeks of pregnancy. Pregnant women complained of the sudden appearance of copious watery discharge from the genital tract with continued leakage. The examination included a vaginal examination in mirrors for fluid accumulation in the vagina, a positive Amniotest (AmnioTest). The reliability of the results obtained was achieved due to statistical data processing by standard parametric and nonparametric procedures of STATISTICA packages (version 10, StatSoft, Persons. BXXR310F964808FA-V) and Excel, the threshold significance level was assumed to be 0.05.</p></sec><sec><title>Results</title><p>The characteristics of pregnant women in the PROM and PPROM groups were comparable in age, number of births, time since the last birth, blood pressure and body mass index (p &gt;0.05) (Tables 1, 2).</p><table-wrap id="table-1"><caption><p>Table 1</p><p>Characteristics of women in labor and coexisting conditions in the examined groups</p></caption><table><tbody><tr><td> </td><td>PROM
(n = 173)</td><td>PPROM
(n = 41)</td><td>P</td></tr><tr><td>Characteristics of a woman in labor (Mean ± SD)</td></tr><tr><td>Age (years)</td><td>29.16 ± 4.50</td><td>28.69 ± 4.91</td><td>0.27</td></tr><tr><td>Number of pregnancies</td><td>1.92 ± 1.16</td><td>2.18 ± 1.34</td><td>0.02</td></tr><tr><td>Number of births</td><td>0.26 ± 0.45</td><td>0.31 ± 0.5</td><td>0.33</td></tr><tr><td>Last birth (years)</td><td>1.74 ± 3.71</td><td>1.93 ± 3.85</td><td>0.60</td></tr><tr><td>Gestational age (weeks)</td><td>39.0 ± 1.50</td><td>34.30 ± 2.0</td><td>0.0</td></tr><tr><td>SBP (mmHg)</td><td>119.66 ± 10.74</td><td>120.54 ± 10.63</td><td>0.38</td></tr><tr><td>DBP (mmHg)</td><td>76.05 ± 7.73</td><td>75.48 ± 8.37</td><td>0.45</td></tr><tr><td>BMI (kg/m2)</td><td>27.09 ± 3.15</td><td>27.22 ± 3.83</td><td>0.67</td></tr><tr><td>CRP</td><td>6.43 ± 65.63</td><td>7.76 ± 6.59</td><td>0.01</td></tr><tr><td>Admission body temperature (°C)</td><td>36.67 ± 0.31</td><td>36.76 ± 0.34</td><td>0.0</td></tr><tr><td>Coexisting conditions of a woman in labor, (%)</td></tr><tr><td>Hypertension</td><td>1.7</td><td>4.4</td><td>0.06</td></tr><tr><td>GD</td><td>21</td><td>19</td><td>0.60</td></tr><tr><td>History of CS</td><td>4.7</td><td>14.6</td><td>0.0</td></tr><tr><td>Breech presentation</td><td>1.9</td><td>9.5</td><td>0.0</td></tr><tr><td>Placenta previa</td><td>0.2</td><td>0</td><td>0.62</td></tr><tr><td>Carrier of HBV</td><td>1.9</td><td>4.4</td><td>0.08</td></tr><tr><td>Placental insufficiency, Fetal growth restriction</td><td>2.1</td><td>2.9</td><td>0.55</td></tr></tbody></table></table-wrap><p>There were significant differences between the two groups in the terms of pregnancy when the rupture of the fetal bladder occurred (39 ± 1.5 weeks vs. 34.3 ± 2.0 weeks, p &lt;0.05), the number of pregnancies (1.92 ± 1.16 vs. 2.18 ± 1.34, p &lt;0.05), CRP (6.43 ± 5.63 vs. 7.76 ± 6.59 mg/l, p &lt;0.05) and body temperature at admission (36.67 ± 0.31 vs. 36.76 ± 0.34, p &lt;0.05). As for concomitant diseases in women in labor, there were no significant differences between patients with hypertensive disorders, gestational diabetes mellitus, placenta previa, fetal growth restriction, placental insufficiency (p &gt;0.05). The frequency of patients with a history of cesarean section and patients with breech presentation was significantly higher in the PPROM group compared to the PROM group (14.6% vs. 4.7% and 9.5% vs. 1.9%, p &lt;0.05).</p><p>The analysis of the PPROM group (Table 2) did not reveal a significant difference in maternal characteristics between the two subgroups, except for the difference in the gestation period when PROM occurred (30.80 ± 1.10 vs. 35.0 ± 1.40, p &lt;0.05). Regarding concomitant pathology in the mother, the study showed that the percentage of patients with previous cesarean section was significantly higher in the group of earlier gestational age (28.6% vs. 12.1%, p &lt;0.05).</p><table-wrap id="table-2"><caption><p>Table 2</p><p>Characteristics of women in labor and coexisting conditions, gestational ages of 28–31.6 weeks vs. 32–36.6 weeks</p></caption><table><tbody><tr><td> </td><td>28–31.6
(n = 15)</td><td>32–36.6
(n =26)</td><td>P</td></tr><tr><td>Characteristics of a woman in labor (Mean ± SD)</td></tr><tr><td>Age (years)</td><td>28.33 ± 5.46</td><td>28.75 ± 4.83</td><td>0.72</td></tr><tr><td>Number of pregnancies</td><td>2.38 ± 1.39</td><td>2.15 ± 1.33</td><td>0.46</td></tr><tr><td>Number of births</td><td>0.43 ± 0.59</td><td>0.28 ± 0.49</td><td>0.23</td></tr><tr><td>Last birth (years)</td><td>2.57 ± 4.33</td><td>1.81 ± 3.77</td><td>0.40</td></tr><tr><td>Gestational age (weeks)</td><td>30.80 ± 1.10</td><td>35.0 ± 1.40</td><td>0.00</td></tr><tr><td>SBP (mmHg)</td><td>123.33 ± 9.99</td><td>120.03 ± 10.71</td><td>0.19</td></tr><tr><td>DBP (mmHg)</td><td>75.76 ± 11.69</td><td>75.43 ± 7.69</td><td>0.86</td></tr><tr><td>BMI (kg/m2)</td><td>27.50 ± 5.31</td><td>27.17 ± 3.52</td><td>0.72</td></tr><tr><td>C-reactive protein</td><td>8.52 ± 7.16</td><td>7.62 ± 6.51</td><td>0.56</td></tr><tr><td>Admission body temperature (°C)</td><td>36.85 ± 0.34</td><td>36.74 ± 0.34</td><td>0.16</td></tr><tr><td>Concomitant diseases of a woman in labor, (%)</td></tr><tr><td>Hypertension</td><td>4.8</td><td>4.3</td><td>0.92</td></tr><tr><td>GD</td><td>14.3</td><td>19.8</td><td>0.55</td></tr><tr><td>History of CS</td><td>28,6</td><td>12,1</td><td>0,04</td></tr><tr><td>Breech presentation</td><td>19</td><td>7.8</td><td>0.35</td></tr><tr><td>Placenta previa</td><td>0</td><td>0</td><td>-</td></tr><tr><td>Carrier of HBV</td><td>9,5</td><td>3,4</td><td>0,21</td></tr><tr><td>Placental insufficiency, Fetal growth restriction</td><td>4,8</td><td>2,6</td><td>0,58</td></tr></tbody></table></table-wrap><p>As for obstetric outcomes for the mother (Table 3), there were no significant differences between the PROM and PPROM groups in terms of the method of childbirth and postpartum bleeding (p &gt;0.05), but the PPROM group had a significantly longer latency period before childbirth (43.29 ± 50.33 hours versus 18.94 ± 17.11 hours, p &lt;0.05). From the point of view of neonatal outcomes (Table 3), newborns in the PROM group had a significantly higher birth weight (3389.17 ± 453.88 vs. 2468.25 ± 551.63, p &lt;0.05), the degree of meconium staining (10.6% vs. 3.6%, p &lt;0.05), data on the APGAR score after 1 minute (7.94 ± 0.41 9 vs. 7.44 ± 1.21, p &lt;0.05) and data on the APGAR score after 5 minutes (8.28 ± 0.22 vs. 7.71 ± 0.91, p &lt;0.05). The rate of hospitalization in the NICU was significantly higher in the PPROM group than in the PROM group (65.7% vs. 11.8%, p &lt;0.05).</p><table-wrap id="table-3"><caption><p>Table 3</p><p>Maternal and neonatal outcomes in the PROM and PPROM groups</p></caption><table><tbody><tr><td> </td><td>PROM
(n = 173)</td><td>PPROM
(n = 41)</td><td>P</td></tr><tr><td>Characteristics of a woman in labor (Mean ± SD)</td></tr><tr><td>Latency period (h)</td><td>18.94 ± 17.11</td><td>43.29 ± 50.33</td><td>0.0</td></tr><tr><td>Method of delivery</td></tr><tr><td>Natural</td><td>431 (74.70)</td><td>96 (70.10)</td><td>0.26</td></tr><tr><td>Cesarean section</td><td>146 (25.30)</td><td>41 (29.90)</td><td> </td></tr><tr><td>PPB</td><td>44 (7.60)</td><td>6 (4.40)</td><td>0.18</td></tr><tr><td>Characteristics of the newborn, Mean ± SD or n (%)</td></tr><tr><td>Birth weight (kg)</td><td>3389.17 ± 453.88</td><td>2468.25 ± 551.63</td><td>0.0</td></tr><tr><td>Meconium staining</td><td>61 (10.60)</td><td>5 (3.60)</td><td>0.01</td></tr><tr><td>APGAR score 1 min</td><td>7.94 ± 0.41</td><td>7.44 ± 1.21</td><td>0.0</td></tr><tr><td>APGAR score 5 min</td><td>8.28 ± 0.22</td><td>7.71 ± 90.91</td><td>0.0</td></tr><tr><td>Hospitalization in the NICU</td><td>11.8</td><td>65.7%</td><td>0.0</td></tr></tbody></table></table-wrap><p>The analysis of the PPROM subgroup (Table 4) also revealed no significant differences between the two subgroups in terms of the method of delivery and postpartum bleeding (p &gt;0.05), but the latency period was significantly longer at an earlier gestational age (91.52 ± 56.94 h versus 34.56 ± 43.94 h, p &lt;0.05). Newborns at 32-36.6 weeks gestation had a significantly higher APGAR score after 1 minute (8.58 ± 1.02 vs. 7.67 ± 1.82, p &lt;0.05), and the frequency of hospitalization in the NICU was significantly higher at the gestational age of 28-31.6 weeks (100% vs. 57.6%, p &lt;0.05).</p><table-wrap id="table-4"><caption><p>Table 4</p><p>Maternal and neonatal outcomes, gestational ages of 28–31.6 weeks vs. 32–36.6 weeks</p></caption><table><tbody><tr><td> </td><td>28-31.6
(n = 15)</td><td>32- 36.6
(n = 26)</td><td>P</td></tr><tr><td>Characteristics of a woman in labor (Mean ± SD)</td></tr><tr><td>Latency period (h)</td><td>91.52 ± 56.94</td><td>34.56 ± 43.94</td><td>0.0</td></tr><tr><td>Method of delivery</td></tr><tr><td>Natural</td><td>13 (61.9%)</td><td>83(71.6%)</td><td>0.37</td></tr><tr><td>Cesarean section</td><td>8 (38.1%)</td><td>33(28.4%)</td><td> </td></tr><tr><td>PPB</td><td>2 (9.5%)</td><td>4 (3.4%)</td><td>0.21</td></tr><tr><td>Characteristics of the newborn, Mean ± SD or n (%)</td></tr><tr><td>Birth weight (kg)</td><td>1716.67 ± 367.19</td><td>2604.3 ± 463.23</td><td>0.07</td></tr><tr><td>Meconium staining</td><td>2(9.5%)</td><td>3 (2.6%)</td><td>0.11</td></tr><tr><td>APGAR score 1 min</td><td>7.67 ± 1.82</td><td>8.58 ± 1.02</td><td>0.0</td></tr><tr><td>APGAR score 5 min</td><td>9.43 ± 0.81</td><td>9.76 ± 0.92</td><td>0.19</td></tr><tr><td>Hospitalization in the NICU</td><td>15 (100%)</td><td>15 (57.6%)</td><td>0.0</td></tr></tbody></table></table-wrap></sec><sec><title>Discussion</title><p>According to this study, women in the PPROM group had significantly higher levels of CRP and body temperature compared to the PROM group (p &lt;0.05). It is well known that CRP is released by the body in response to acute injury, infection or other inflammatory stimuli and is a leading marker in the blood of systemic inflammation. Its value is a general indicator. A high or increasing amount of CRP in the blood suggests the presence of inflammation, but does not allow to determine its location or the condition causing it. It is assumed that the proinflammatory cytokine interleukin-6 plays a crucial role in the induction of fever and in the synthesis of CRP by hepatocytes. The data obtained are consistent with the information provided in published reliable sources [<xref ref-type="bibr" rid="cit6">6</xref>][<xref ref-type="bibr" rid="cit7">7</xref>].</p><p>The study showed that PPROM is associated with a significantly lower gestational age, patients of this group demonstrated a higher level of C-reactive protein and body temperature upon admission to the maternity hospital (p &lt;0.05). Breech presentation and previous cesarean section in the anamnesis were associated with the occurrence of PPROM in comparison with the PROM group (p &lt;0.05). The PPROM group showed a significantly longer latency period compared with the PROM group, in which the latency period increased with a lower gestational age (28-31.6 weeks). A significantly higher rate of admission to the neonatal intensive care unit (NICU) was observed in the PPROM group in comparison with the PROM group, and also at the gestational age of 28-31.6 weeks, a more significant rate of admission to the NICU was shown in comparison with the gestational age of 32-36.6 weeks (p &lt;0.05). Higher levels of C-reactive protein and body temperature in the PPROM group suggest an asymptomatic infection that requires careful monitoring to prevent any adverse effect on the outcome of pregnancy. A longer latency period in the PPROM group is predictable to minimize perinatal morbidity and mortality from prematurity itself [<xref ref-type="bibr" rid="cit8">8</xref>].</p><p>This particular study showed that patients in the PPROM group were more likely to have breech presentation compared to the PROM group (9.5% vs. 1.9%, p &lt;0.05). These results are consistent with the literature sources [<xref ref-type="bibr" rid="cit9">9</xref>][<xref ref-type="bibr" rid="cit10">10</xref>]. After the division into subgroups, there were no differences in the presentation of the fetus with a predominance in the PPROM group. The authors of this study assumed that the shorter the gestation period, the higher the probability of breech presentation. The natural correlation between breech presentation and earlier gestation combined with PPROM explains why we found a significant correlation between PPROM and breech presentation.</p><p>It was revealed that the previous cesarean section in the anamnesis significantly correlated with PPROM, and not with PROM (14.6% vs. 4.7%, p &lt;0.05). After the distribution into subgroups, the earlier gestational age had a significantly higher level of previous cesarean section in the anamnesis (28.6% vs. 12.1%, p &lt;0.05). Unfortunately, the authors of this study were unable to explain the correlation between the previous caesarean section and the PPROM. Perhaps these results were influenced by our study sample, which was not large enough.</p><p>As for maternal outcomes, the PPROM group had a significantly longer latency period than the PROM group. After the division into subgroups, the duration of the latency period was significantly longer at the gestational age of 28-31.6 weeks than at 32-36.6 weeks. The main problem of PPROM is prematurity, therefore, the latency period affects the outcomes for the mother and fetus. A study of 1,596 patients with PDR conducted by Drassinower et al. [<xref ref-type="bibr" rid="cit11">11</xref>], showed that a long latency period in the conditions of PPROM was associated with a reduced risk of neonatal sepsis and that infants born shortly after PPROM were at the highest risk. Periventricular leukomalacia is damage to the white matter of the brain of premature newborns, which often leads to cerebral palsy. The prevalence of cerebral palsy at the age of 3 years is 21 per 1000 among those born at the age of 28 to 30 weeks and 0.6 per 1000 among those born at term. Therefore, when appropriate, wait-and-see tactics are usually recommended in the absence of labor or complications associated with childbirth in order to minimize perinatal morbidity and mortality [<xref ref-type="bibr" rid="cit12">12</xref>].</p><p>During hospitalization in the absence of indications for delivery, all pregnant women were observed conservatively and expectantly: treatment was carried out in accordance with a standardized protocol. This included careful monitoring of the mother's condition, regular monitoring of the fetal heart rate and a blood test. Tocolysis and antenatal administration of steroids are common practice in the conditions of PPROM (four doses of dexamethasone 6 mg were administered intramuscularly at intervals of 12 hours for 2 days). In addition, prophylaxis with antibiotics was carried out. Tocolytic therapy suppresses uterine contractions and allows the administration of steroids and antibiotics. The decision to terminate the pregnancy by Caesarean section or normal delivery was based on the status of the mother and fetus. Cesarean section was mainly indicated for complications of pregnancy, for example, with maternal fever, the presence of clinical chorioamnionitis, unfavorable fetal status and death, as well as placental abruption.</p><p>As for neonatal outcomes, as expected, infants in the PROM group had a significantly higher birth weight and an APGAR score 1 minute and 5 minutes after delivery (p &lt;0.05). The indicator of amniotic fluid staining with meconium was also significantly higher in the PROM group than in the PPROM group (p &lt;0.05). Meconium is often found in amniotic fluid and placental samples, especially in full-term or post-term pregnancy. The physiological tendency of the fetus to secrete meconium increases with gestation. The results of this study corresponded to the literature data [<xref ref-type="bibr" rid="cit13">13</xref>][<xref ref-type="bibr" rid="cit14">14</xref>]. The rate of hospitalization in the ICU was significantly higher in the PPROM group than in the PROM group (p &lt;0.05). After the division into subgroups, there were no differences in birth weight, meconium staining frequency and APGAR scores after 5 minutes (p &gt;0.05), but APGAR scores after 1 minute were higher at a later stage of pregnancy. The authors of this study found a significantly higher frequency of hospitalizations in the NICU at the gestational age of 28-31.6 weeks compared with 32-36.6 weeks (100% vs. 57.6%, p &lt;0.05). This showed that even if both subgroups did not reach the due date, an increase in the duration of pregnancy plays an important role that can influence the decision to transfer to the intensive care unit.</p></sec><sec><title>Conclusion</title><p>A higher C-reactive protein index and body temperature in the PPROM group suggest an asymptomatic infection that requires careful monitoring to prevent any adverse effect on the outcome of pregnancy. Patients with a previous cesarean section and a history of breech presentation strongly correlate with the occurrence of PPROM compared with PROM, in whom the history of the previous cesarean section remains correlated with a lower gestational age (28-31. 6 weeks). A longer latency period in the PPROM group compared to the PROM group is important for minimizing perinatal morbidity and mortality due to prematurity itself. Thus, an increase in gestational age plays an important role, and can also influence the doctor's decision regarding the placement of a newborn in the NICU.</p><p>A higher C-reactive protein index and body temperature in the PPROM group suggest an asymptomatic infection that requires careful monitoring to prevent any adverse effect on the outcome of pregnancy. Patients with a previous cesarean section and a history of breech presentation are a high-risk group for the occurrence of PPROM compared with PROM, in whom the history of the previous cesarean section remains correlated with a lower gestational age (28-31.6 weeks). A longer anhydrous period in the PPROM group compared to the PROM group is important for minimizing perinatal morbidity and mortality due to prematurity itself. Thus, an increase in gestational age plays an important role, and can also influence the doctor's decision regarding the placement of a newborn in the NICU.</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Xia H, Li X, Li X, Liang H, Xu H. The clinical management and outcome of term premature rupture of membrane in East China: results from a retrospective multicenter study. Int J Clin Exp Med. 2015; 8(4):6212-7. PMID: 26131227; PMCID: PMC4483966.</mixed-citation><mixed-citation xml:lang="en">Xia H, Li X, Li X, Liang H, Xu H. The clinical management and outcome of term premature rupture of membrane in East China: results from a retrospective multicenter study. Int J Clin Exp Med. 2015; 8(4):6212-7. PMID: 26131227; PMCID: PMC4483966.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Yu H, Wang X, Gao H, You Y, Xing A. Perinatal outcomes of pregnancies complicated by preterm premature rupture of the membranes before 34 weeks of gestation in a tertiary center in China: A retrospective review. Biosci Trends. 2015; 9(1):35-41. DOI: 10.5582/bst.2014.01058.</mixed-citation><mixed-citation xml:lang="en">Yu H, Wang X, Gao H, You Y, Xing A. Perinatal outcomes of pregnancies complicated by preterm premature rupture of the membranes before 34 weeks of gestation in a tertiary center in China: A retrospective review. Biosci Trends. 2015; 9(1):35-41. DOI: 10.5582/bst.2014.01058.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">da Fonseca EB, Damião R, Moreira DA. Preterm birth prevention. Best Pract Res Clin Obstet Gynaecol. 2020; 69:40-49. DOI: 10.1016/j.bpobgyn.2020.09.003.</mixed-citation><mixed-citation xml:lang="en">da Fonseca EB, Damião R, Moreira DA. Preterm birth prevention. Best Pract Res Clin Obstet Gynaecol. 2020; 69:40-49. DOI: 10.1016/j.bpobgyn.2020.09.003.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Morris JM, Roberts CL, Bowen JR, Patterson JA, Bond DM, et al. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet. 2016; 387(10017):444-52. DOI: 10.1016/S0140-6736(15)00724-2.</mixed-citation><mixed-citation xml:lang="en">Morris JM, Roberts CL, Bowen JR, Patterson JA, Bond DM, et al. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet. 2016; 387(10017):444-52. DOI: 10.1016/S0140-6736(15)00724-2.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ream MA, Lehwald L. Neurologic Consequences of Preterm Birth. Curr Neurol Neurosci Rep. 2018; 18(8):48. DOI: 10.1007/s11910-018-0862-2.</mixed-citation><mixed-citation xml:lang="en">Ream MA, Lehwald L. Neurologic Consequences of Preterm Birth. Curr Neurol Neurosci Rep. 2018; 18(8):48. DOI: 10.1007/s11910-018-0862-2.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kim MA, Lee BS, Park YW, Seo K. Serum markers for prediction of spontaneous preterm delivery in preterm labour. Eur J Clin Invest. 2011; 41(7):773-80. DOI: 10.1111/j.1365-2362.2011.02469.x.</mixed-citation><mixed-citation xml:lang="en">Kim MA, Lee BS, Park YW, Seo K. Serum markers for prediction of spontaneous preterm delivery in preterm labour. Eur J Clin Invest. 2011; 41(7):773-80. DOI: 10.1111/j.1365-2362.2011.02469.x.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dotters-Katz S. Antibiotics for Prophylaxis in the Setting of Preterm Prelabor Rupture of Membranes. Obstet Gynecol Clin North Am. 2020; 47(4):595-603. DOI: 10.1016/j.ogc.2020.08.005.</mixed-citation><mixed-citation xml:lang="en">Dotters-Katz S. Antibiotics for Prophylaxis in the Setting of Preterm Prelabor Rupture of Membranes. Obstet Gynecol Clin North Am. 2020; 47(4):595-603. DOI: 10.1016/j.ogc.2020.08.005.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jacobsson B, Saltvedt S, Wikström AK, Morken NH, Leijonhufvud Å, Hagberg H. Prediktion, prevention och behandlingsmetoder [Preterm delivery: an overview on prediction, prevention and treatment]. Lakartidningen. 2019; 116:FSST. (In Swedish). PMID: 31593290.</mixed-citation><mixed-citation xml:lang="en">Jacobsson B, Saltvedt S, Wikström AK, Morken NH, Leijonhufvud Å, Hagberg H. Prediktion, prevention och behandlingsmetoder [Preterm delivery: an overview on prediction, prevention and treatment]. Lakartidningen. 2019; 116:FSST. (In Swedish). PMID: 31593290.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cammu H, Dony N, Martens G, Colman R. Common determinants of breech presentation at birth in singletons: a population-based study. Eur J Obstet Gynecol Reprod Biol. 2014; 177:106-9. DOI: 10.1016/j.ejogrb.2014.04.008.</mixed-citation><mixed-citation xml:lang="en">Cammu H, Dony N, Martens G, Colman R. Common determinants of breech presentation at birth in singletons: a population-based study. Eur J Obstet Gynecol Reprod Biol. 2014; 177:106-9. DOI: 10.1016/j.ejogrb.2014.04.008.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sim WH, Araujo Júnior E, Da Silva Costa F, Sheehan PM. Maternal and neonatal outcomes following expectant management of preterm prelabour rupture of membranes before viability. J Perinat Med. 2017; 45(1):29-44. DOI: 10.1515/jpm-2016-0183.</mixed-citation><mixed-citation xml:lang="en">Sim WH, Araujo Júnior E, Da Silva Costa F, Sheehan PM. Maternal and neonatal outcomes following expectant management of preterm prelabour rupture of membranes before viability. J Perinat Med. 2017; 45(1):29-44. DOI: 10.1515/jpm-2016-0183.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Drassinower D, Friedman AM, Običan SG, Levin H, Gyamfi-Bannerman C. Prolonged latency of preterm premature rupture of membranes and risk of neonatal sepsis. Am J Obstet Gynecol. 2016; 214(6):743.e1-6. DOI: 10.1016/j.ajog.2015.12.031.</mixed-citation><mixed-citation xml:lang="en">Drassinower D, Friedman AM, Običan SG, Levin H, Gyamfi-Bannerman C. Prolonged latency of preterm premature rupture of membranes and risk of neonatal sepsis. Am J Obstet Gynecol. 2016; 214(6):743.e1-6. DOI: 10.1016/j.ajog.2015.12.031.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Suff N, Story L, Shennan A. The prediction of preterm delivery: What is new? Semin Fetal Neonatal Med. 2019; 24(1):27- 32. DOI: 10.1016/j.siny.2018.09.006.</mixed-citation><mixed-citation xml:lang="en">Suff N, Story L, Shennan A. The prediction of preterm delivery: What is new? Semin Fetal Neonatal Med. 2019; 24(1):27- 32. DOI: 10.1016/j.siny.2018.09.006.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sibiude J. Rupture des membranes à terme avant travail. Recommandations pour la pratique clinique du CNGOF — Fautil déclencher ? [Term Prelabor Rupture of Membranes: CNGOF Guidelines for Clinical Practice — Timing of Labor Induction]. Gynecol Obstet Fertil Senol. 2020; 48(1):35-47. (In French). DOI: 10.1016/j.gofs.2019.10.015.</mixed-citation><mixed-citation xml:lang="en">Sibiude J. Rupture des membranes à terme avant travail. Recommandations pour la pratique clinique du CNGOF — Fautil déclencher ? [Term Prelabor Rupture of Membranes: CNGOF Guidelines for Clinical Practice — Timing of Labor Induction]. Gynecol Obstet Fertil Senol. 2020; 48(1):35-47. (In French). DOI: 10.1016/j.gofs.2019.10.015.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Girsen AI, Wallenstein MB, Davis AS, Hintz SR, Desai AK, et al. Effect of antepartum meconium staining on perinatal and neonatal outcomes among pregnancies with gastroschisis. J Matern Fetal Neonatal Med. 2016; 29(15):2500-4. DOI: 10.3109/14767058.2015.1090971.</mixed-citation><mixed-citation xml:lang="en">Girsen AI, Wallenstein MB, Davis AS, Hintz SR, Desai AK, et al. Effect of antepartum meconium staining on perinatal and neonatal outcomes among pregnancies with gastroschisis. J Matern Fetal Neonatal Med. 2016; 29(15):2500-4. DOI: 10.3109/14767058.2015.1090971.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
